Clinical trial
Thalassemia Screening by Third Generation Sequencing (TGS): Pilot Study in Thai Population
NCT05552690 is registered in ClinicalTrials.gov with Chiang Mai University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thalassemia Screening by Third Generation Sequencing (TGS): Pilot Study in Thai Population
- Lead sponsor
- Chiang Mai University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 1, 2022
- Completion date
- May 31, 2023
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thalassemia trait, thalassemia; mixed